COGT Operating Cash Flow (Statement)
Cogent Biosciences Inc · Operating Cash Flow (Statement)
COGT Operating Cash Flow (Statement)
Latest reported-$77.27Mperiod ending
COGT Quarterly Cash from Operations ($0.00 → -$77.27M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
COGT operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -77,271,000 | |
| -86,883,000 | |
| -79,105,000 | |
| -64,286,000 | |
| -54,542,000 | |
| -66,511,000 | |
| -60,577,000 | |
| -51,984,000 | |
| -42,701,000 | |
| -52,529,000 | |
| -44,070,000 | |
| -37,971,000 | |
| -32,066,000 | |
| -39,517,000 | |
| -29,408,000 | |
| -34,440,000 | |
| -26,456,000 | |
| -28,334,000 | |
| -20,777,000 | |
| -14,109,000 | |
| -12,511,000 | |
| -11,366,000 | |
| -9,366,000 | |
| -10,267,000 | |
| -8,324,000 | |
| -7,893,000 | |
| -8,445,000 | |
| -10,207,000 | |
| -11,344,000 | |
| -11,518,000 | |
| -9,020,000 | |
| -7,575,000 | |
| -7,913,000 | |
| -7,981,000 | |
| -6,516,000 | |
| -6,290,000 | |
| -5,761,000 | |
| -7,268,000 | |
| 0 | |
| 0 |